openPR Logo
Press release

Drugs of Abuse Testing Market Report Up to 2031

09-14-2021 08:26 AM CET | Health & Medicine

Press release from: Visiongain Pharma

Visiongain has published a new report on Drugs of Abuse Testing Market Report 2021-2031 : Forecasts by Product Type (Analyzers, Rapid Testing Devices, Consumables, and Laboratory Services), by Sample Type (Saliva, Breath, Urine, Blood, Hair, Sweat, and Others), by Testing Type (Onsite Screening Testing, and Laboratory Drug Testing), by Drug Type (Alcohol, Cannabis, Opioids, Amphetamine, LSD, and Others), by Patient Demographics (Geriatric Patient, Adult Patient, and Pediatric), by End User (Hospitals, Workplaces & Schools, Criminal Justice Systems & Law Enforcement Agencies, Diagnostics Laboratories, On-the-spot Testing, Forensic Laboratories, Specialty Clinics, and Others), by Distribution Channel (Direct Tender, and Retail Sales) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/drugs-of-abuse-testing-market-2021/#download_sampe_div

COVID-19 Impact on Drugs of Abuse Testing Market
COVID-19 has impacted different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Drugs of Abuse Testing market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analysed herein the report are mentioned below:

Market Drivers

Increasing Drugs Abuse
Drug abuse or inappropriate usage of substances (prescription medication, alcohol) is one of major issue in the developed countries. Drug abuse use to be developed as an addiction. The drugs abuse can have serious consequences on a person’s mental health, physical health, and overall well-being. Drugs Abuse has risen very significantly in few last year as compared to previous once and expected to continuously rise over the forecast period. The increase in the drugs abuse creates a huge demand for the drugs of abuse testing products.

Market Opportunities

Government initiative and awareness program
Governments in various counties are increasing their initiatives to increase awareness regarding repercussion associated with Drug abuse. Governments and regulatory authority across the world has illegalized Drug abuse or inappropriate usage of substances (prescription medication, alcohol) and are focusing on increasing number of addiction treatment centres and new approval for drug abuse. Increasing government initiative and awareness program is expected to increase demand of drug abuse testing in the forecasted period. Due to this reason the factor is creating various opportunities for drugs of abuse testing market.

Get Detailed TOC @ https://www.visiongain.com/report/drugs-of-abuse-testing-market-2021/#download_sampe_div

Technological Advancements and the Modernization in Addiction Treatment
Manufactures from all over the world are increasing research and development activities for advancement and modernization of drugs of abuse testing addiction treatment particularly for alcohol, cannabis, opioids, amphetamine, LSD, and Ot helps to accurateness and to reduce require time. New research and development activities are expected to create competitive advantages and increase demand of drugs of abuse analyzers, rapid testing devices, consumables, and laboratory services in the forecasted period. Due to this reason the factor is creating various opportunities for drugs of abuse testing market.

Competitive Landscape
Top companies (F. Hoffmann-La Roche AG, AbbVie, Inc., Mallinckrodt plc and Pfizer, Inc.) constitute more than XX% share of the global Drugs of Abuse Testing market. Other companies profiled in the report include: Sun Pharmaceutical Ltd., Ampac Fine Chemicals, GW Pharmaceuticals plc, Merck & Co., Inc., Depomed, Inc., Coating Place, Inc., Corium International, Inc., Johnson and Johnson Services, Inc., Alkermes plc, Pfizer, Inc. and Orbis Biosciences, Inc.among others Some of the key developments are listed below:
• In 2019, Omeros Corporation has published positive results from OMS527 program Phase 1 study, a inhibitors for the treatment of addictions. Through this development company will widened their market focused product portfolio.

Request Customized Report as Per Your Requirements @ https://www.visiongain.com/contact/

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Drugs of Abuse Testing Market and leading companies. You will find data, trends and predictions.

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com

Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Research Insight : https://www.visiongain.com/drugs-of-abuse-testing-market-analysis/

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drugs of Abuse Testing Market Report Up to 2031 here

News-ID: 2391524 • Views: 121

More Releases from Visiongain Pharma

Balloon Catheter Market Report Up to 2031
Visiongain has published a new report on Balloon Catheter Market Report to 2031. Profiles of Leading Balloon Catheter Market players, Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. The global Balloon Catheter Market is growing significantly owing to rising surgeries, technological advancement in surgeries and growing incidence and prevalence rate of heart diseases such as Cardiovascular Disease (CVD), Coronary Heart Disease (CHD), around the globe. The rising awareness campaigns,
Balanced Salt Solution for Cell Culture Market Report Up to 2031
Visiongain has published a new report on Balanced Salt Solution For Cell Culture Market Report to 2031. Profiles of Leading Balanced Salt Solution For Cell Culture Market players, Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. The global Balanced Salt Solution For Cell Culture Market has been growing significantly due to various factors such as rising investment in the cell culture domain, growing incidence and prevalence of chronic diseases,
Bacterial Conjunctivitis Market Report Up to 2031
Visiongain has published a new report on Bacterial Conjunctivitis Market Report to 2031. Profiles of Leading Bacterial Conjunctivitis Market players, Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/bacterial-conjunctivitis-market/#download_sampe_div A conjunctivitis is a communicable disease which is also known as pink eye in the US. The bacterial conjunctivitis is an inflammation of the conjunctiva which can be caused by bacteria, viruses, and allergens. It
Autotransfusion Systems Market Report Up to 2031
Visiongain has published a new report on Autotransfusion Systems Market Report to 2031. Profiles of Leading Autotransfusion Systems Market players, Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Autotransfusion Systems is widely used to provide autologous blood during surgical procedures. In this process autotransfusion systems allows the transfusion of the patient’s blood rather than using the banked allogenic blood. It is incredibly useful during the critical procedures such as

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning